Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

Cell

Volumn 163, Issue 2, 2015, Pages 506-519

  Ciriello, Giovanni ^a,b   Gatza, Michael L ^c,d   Beck, Andrew H ^e   Wilkerson, Matthew D ^f   Rhie, Suhn K ^g   Pastore, Alessandro ^b   Zhang, Hailei ^h   McLellan, Michael ⁱ   Yau, Christina ^j   Kandoth, Cyriac ^b   Bowlby, Reanne ^k   Shen, Hui ^l   Hayat, Sikander ^b   Fieldhouse, Robert ^b   Lester, Susan C ^e   Tse, Gary M K ^m   Factor, Rachel E ⁿ   Collins, Laura C ^e   Allison, Kimberly H ^o   Chen, Yunn Yi ^q   Jensen, Kristin ^o,p   Johnson, Nicole B ^e   Oesterreich, Steffi ^r   Mills, Gordon B ^s   Cherniack, Andrew D ^h   Robertson, Gordon ^k   Benz, Christopher ^j   Sander, Chris ^b   Laird, Peter W ^l   Hoadley, Katherine A ^c   King, Tari A ^b   Akbani, Rehan ^t   Auman, J Todd ^t   Balasundaram, Miruna ^t   Balu, Saianand ^t   Barr, Thomas ^t   Benz, Stephen ^t   Berrios, Mario ^t   Beroukhim, Rameen ^t   Bodenheimer, Tom ^t   Boice, Lori ^t   Bootwalla, Moiz S ^t   Bowen, Jay ^t   Brooks, Denise ^t   Chin, Lynda ^t   Cho, Juok ^t   Chudamani, Sudha ^t   Davidsen, Tanja ^t   Demchok, John A ^t   Dennison, Jennifer B ^t   Ding, Li ^t   Felau, Ina ^t   Ferguson, Martin L ^t   Frazer, Scott ^t   Gabriel, Stacey B ^t   Gao, JianJiong ^t   Gastier Foster, Julie M ^t   Gehlenborg, Nils ^t   Gerken, Mark ^t   Getz, Gad ^t   Gibson, William J ^t   Hayes, D Neil ^t   Heiman, David I ^t   Holbrook, Andrea ^t   Holt, Robert A ^t   Hoyle, Alan P ^t   Hu, Hai ^t   Huang, Mei ^t   Hutter, Carolyn M ^t   Hwang, E Shelley ^t   Jefferys, Stuart R ^t   Jones, Steven J M ^t   Ju, Zhenlin ^t   Kim, Jaegil ^t   Lai, Phillip H ^t   Lawrence, Michael S ^t   Leraas, Kristen M ^t   Lichtenberg, Tara M ^t   Lin, Pei ^t   Ling, Shiyun ^t   Liu, Jia ^t   Liu, Wenbin ^t   Lolla, Laxmi ^t   Lu, Yiling ^t   Ma, Yussanne ^t   Maglinte, Dennis T ^t   Mardis, Elaine ^t   Marks, Jeffrey ^t   Marra, Marco A ^t   McAllister, Cynthia ^t   Meng, Shaowu ^t   Meyerson, Matthew ^t   Moore, Richard A ^t   Mose, Lisle E ^t   Mungall, Andrew J ^t   Murray, Bradley A ^t   Naresh, Rashi ^t   Noble, Michael S ^t   Olopade, Olufunmilayo ^t   Parker, Joel S ^t   Pihl, Todd ^t   Saksena, Gordon ^t   Schumacher, Steven E ^t   Shaw, Kenna R Mills ^t   Ramirez, Nilsa C ^t   Rathmell, W Kimryn ^t   Roach, Jeffrey ^t   Robertson, A Gordon ^t   Schein, Jacqueline E ^t   Schultz, Nikolaus ^t   Sheth, Margi ^t   Shi, Yan ^t   Shih, Juliann ^t   Shelley, Carl Simon ^t   Shriver, Craig ^t   Simons, Janae V ^t   Sofia, Heidi J ^t   Soloway, Matthew G ^t   Sougnez, Carrie ^t   Sun, Charlie ^t   Tarnuzzer, Roy ^t   Tiezzi, Daniel G ^t   Van Den Berg, David J ^t   Voet, Doug ^t   Wan, Yunhu ^t   Wang, Zhining ^t   Weinstein, John N ^t   Weisenberger, Daniel J ^t   Wilson, Richard ^t   Wise, Lisa ^t   Wiznerowicz, MacIej ^t   Wu, Junyuan ^t   Wu, Ye ^t   Yang, Liming ^t   Zack, Travis I ^t   Zenklusen, Jean C ^t   Zhang, Jiashan ^t   Zmuda, Erik ^t   Perou, Charles M ^c   more..

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^k BRITISH COLUMBIA CANCER AGENCY   (Canada)

^l VAN ANDEL RESEARCH INSTITUTE   (United States)

^m CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^o STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^s UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^t NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TBX3; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; FOXA1 PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTOME;

ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FOLLOW UP; GENE; GENE EXPRESSION; GENE MUTATION; HEPATOCYTE NUCLEAR FACTOR 3ALPHA GENE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; TRANSCRIPTION FACTOR GATA 3 GENE; BREAST TUMOR; CHEMISTRY; DNA MICROARRAY; FEMALE; GENETICS; LUNG CARCINOMA; METABOLISM; MOLECULAR MODEL; MUTATION; PAGET NIPPLE DISEASE; PATHOLOGY;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MODELS, MOLECULAR; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEIN V-AKT; TRANSCRIPTOME;

EID: 84943613527     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.09.033     Document Type: Article

References (66)

1. R. Akbani, P.K. Ng, H.M. Werner, M. Shahmoradgoli, F. Zhang, Z. Ju, W. Liu, J.Y. Yang, K. Yoshihara, J. Li, and et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas Nat. Commun. 5 2014 3887
2. G. Arpino, V.J. Bardou, G.M. Clark, and R.M. Elledge Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res. 6 2004 R149 R156
3. D.P. Arps, P. Healy, L. Zhao, C.G. Kleer, and J.C. Pang Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast Breast Cancer Res. Treat. 138 2013 719 726
4. M. Baay, A. Brouwer, P. Pauwels, M. Peeters, and F. Lardon Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy Clin. Dev. Immunol. 2011 2011 565187
5. S.C. Baca, D. Prandi, M.S. Lawrence, J.M. Mosquera, A. Romanel, Y. Drier, K. Park, N. Kitabayashi, T.Y. MacDonald, M. Ghandi, and et al. Punctuated evolution of prostate cancer genomes Cell 153 2013 666 677
6. C.E. Barbieri, S.C. Baca, M.S. Lawrence, F. Demichelis, M. Blattner, J.P. Theurillat, T.A. White, P. Stojanov, E. Van Allen, N. Stransky, and et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer Nat. Genet. 44 2012 685 689
7. A. Bharat, F. Gao, and J.A. Margenthaler Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers Am. J. Surg. 198 2009 516 519
8. U. Brinck, S. Jacobs, M. Neuss, K. Tory, W. Rath, B. Kulle, and L. Füzesi Diffuse growth pattern affects E-cadherin expression in invasive breast cancer Anticancer Res. 24 2004 2237 2242
9. N. Cancer Genome Atlas Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours Nature 490 2012 61 70
10. Cancer Genome Atlas Research Network Comprehensive molecular characterization of gastric adenocarcinoma Nature 513 2014 202 209
11. L.C. Cantley, and B.G. Neel New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc. Natl. Acad. Sci. USA 96 1999 4240 4245
12. J.S. Carroll, X.S. Liu, A.S. Brodsky, W. Li, C.A. Meyer, A.J. Szary, J. Eeckhoute, W. Shao, E.V. Hestermann, T.R. Geistlinger, and et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 Cell 122 2005 33 43
13. S.L. Carter, K. Cibulskis, E. Helman, A. McKenna, H. Shen, T. Zack, P.W. Laird, R.C. Onofrio, W. Winckler, B.A. Weir, and et al. Absolute quantification of somatic DNA alterations in human cancer Nat. Biotechnol. 30 2012 413 421
14. G. Ciriello, E. Cerami, C. Sander, and N. Schultz Mutual exclusivity analysis identifies oncogenic network modules Genome Res. 22 2012 398 406
15. G. Ciriello, M.L. Miller, B.A. Aksoy, Y. Senbabaoglu, N. Schultz, and C. Sander Emerging landscape of oncogenic signatures across human cancers Nat. Genet. 45 2013 1127 1133
16. G. Ciriello, R. Sinha, K.A. Hoadley, A.S. Jacobsen, B. Reva, C.M. Perou, C. Sander, and N. Schultz The molecular diversity of Luminal A breast tumors Breast Cancer Res. Treat. 141 2013 409 420
17. L.A. Cirillo, and K.S. Zaret Specific interactions of the wing domains of FOXA1 transcription factor with DNA J. Mol. Biol. 366 2007 720 724
18. L.A. Cirillo, F.R. Lin, I. Cuesta, D. Friedman, M. Jarnik, and K.S. Zaret Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4 Mol. Cell 9 2002 279 289
19. M. Cristofanilli, A. Gonzalez-Angulo, N. Sneige, S.W. Kau, K. Broglio, R.L. Theriault, V. Valero, A.U. Buzdar, H. Kuerer, T.A. Buchholz, and G.N. Hortobagyi Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J. Clin. Oncol. 23 2005 41 48
20. C. Curtis, S.P. Shah, S.F. Chin, G. Turashvili, O.M. Rueda, M.J. Dunning, D. Speed, A.G. Lynch, S. Samarajiwa, Y. Yuan, et al. METABRIC Group The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 486 2012 346 352
21. D.J. Dabbs, S.J. Schnitt, F.C. Geyer, B. Weigelt, F.L. Baehner, T. Decker, V. Eusebi, S.B. Fox, S. Ichihara, S.R. Lakhani, and et al. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry Am. J. Surg. Pathol. 37 2013 e1 e11
22. A.R. Dabney ClaNC: point-and-click software for classifying microarrays to nearest centroids Bioinformatics 22 2006 122 123
23. E. Duvallet, L. Semerano, E. Assier, G. Falgarone, and M.C. Boissier Interleukin-23: a key cytokine in inflammatory diseases Ann. Med. 43 2011 503 511
24. C. Fan, A. Prat, J.S. Parker, Y. Liu, L.A. Carey, M.A. Troester, and C.M. Perou Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures BMC Med. Genomics 4 2011 3
25. F.W. Foote Jr., and F.W. Stewart A histologic classification of carcinoma of the breast Surgery 19 1946 74 99
26. K.S. Gajiwala, and S.K. Burley Winged helix proteins Curr. Opin. Struct. Biol. 10 2000 110 116
27. M.L. Gatza, G.O. Silva, J.S. Parker, C. Fan, and C.M. Perou An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer Nat. Genet. 46 2014 1051 1059
28. J.R. Graff, J.G. Herman, S. Myöhänen, S.B. Baylin, and P.M. Vertino Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation J. Biol. Chem. 272 1997 22322 22329
29. C.S. Grasso, Y.M. Wu, D.R. Robinson, X. Cao, S.M. Dhanasekaran, A.P. Khan, M.J. Quist, X. Jing, R.J. Lonigro, J.C. Brenner, and et al. The mutational landscape of lethal castration-resistant prostate cancer Nature 487 2012 239 243
30. H.O. Habashy, D.G. Powe, E.A. Rakha, G. Ball, C. Paish, J. Gee, R.I. Nicholson, and I.O. Ellis Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance Eur. J. Cancer 44 2008 1541 1551
31. J.G. Herman, J.R. Graff, S. Myöhänen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. USA 93 1996 9821 9826
32. A. Hurtado, K.A. Holmes, C.S. Ross-Innes, D. Schmidt, and J.S. Carroll FOXA1 is a key determinant of estrogen receptor function and endocrine response Nat. Genet. 43 2011 27 33
33. M.D. Iglesia, B.G. Vincent, J.S. Parker, K.A. Hoadley, L.A. Carey, C.M. Perou, and J.S. Serody Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer Clin. Cancer Res. 20 2014 3818 3829
34. S. Kohler, and L.A. Cirillo Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling J. Biol. Chem. 285 2010 464 472
35. M.T. Lau, C. Klausen, and P.C. Leung E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression Oncogene 30 2011 2753 2766
36. C.W. Law, Y. Chen, W. Shi, and G.K. Smyth voom: Precision weights unlock linear model analysis tools for RNA-seq read counts Genome Biol. 15 2014 R29
37. M.S. Lawrence, P. Stojanov, P. Polak, G.V. Kryukov, K. Cibulskis, A. Sivachenko, S.L. Carter, C. Stewart, C.H. Mermel, S.A. Roberts, and et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes Nature 499 2013 214 218
38. X. Liu, L. Su, and X. Liu Loss of CDH1 up-regulates epidermal growth factor receptor via phosphorylation of YBX1 in non-small cell lung cancer cells FEBS Lett. 587 2013 3995 4000
39. Z. Liu, D. Merkurjev, F. Yang, W. Li, S. Oh, M.J. Friedman, X. Song, F. Zhang, Q. Ma, K.A. Ohgi, and et al. Enhancer activation requires trans-recruitment of a mega transcription factor complex Cell 159 2014 358 373
40. A.E. McCart Reed, J.R. Kutasovic, S.R. Lakhani, and P.T. Simpson Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics Breast Cancer Res. 17 2015 12
41. C.H. Mermel, S.E. Schumacher, B. Hill, M.L. Meyerson, R. Beroukhim, and G. Getz GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers Genome Biol. 12 2011 R41
42. Metzger, O., Giobbie-Hurder, A., Mallon, E., Viale, G., Winer, E., Thurlimann, B., Gelber, R.D., Colleoni, M., Ejlertsen, B., Bonnefoi, H., et al. (2012). Abstract S1-1: Relative effectiveness of letrozole compared with tamoxifen for patients with lobular carcinoma in the BIG 1-98 trial. In Thirty-Fifth CTRC-AACR San Antonio Breast Cancer Symposium (San Antonio, TX).
43. R. Moll, M. Mitze, U.H. Frixen, and W. Birchmeier Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am. J. Pathol. 143 1993 1731 1742
44. M. Morrogh, V.P. Andrade, D. Giri, R.A. Sakr, W. Paik, L.X. Qin, C.D. Arroyo, E. Brogi, M. Morrow, and T.A. King Cadherin-catenin complex dissociation in lobular neoplasia of the breast Breast Cancer Res. Treat. 132 2012 641 652
45. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, and et al. Supervised risk predictor of breast cancer based on intrinsic subtypes J. Clin. Oncol. 27 2009 1160 1167
46. B.C. Pestalozzi, D. Zahrieh, E. Mallon, B.A. Gusterson, K.N. Price, R.D. Gelber, S.B. Holmberg, J. Lindtner, R. Snyder, B. Thürlimann, et al. International Breast Cancer Study Group Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials J. Clin. Oncol. 26 2008 3006 3014
47. G. Quon, S. Haider, A.G. Deshwar, A. Cui, P.C. Boutros, and Q. Morris Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction Genome Med. 5 2013 29
48. F.M. Richards, S.A. McKee, M.H. Rajpar, T.R. Cole, D.G. Evans, J.A. Jankowski, C. McKeown, D.S. Sanders, and E.R. Maher Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer Hum. Mol. Genet. 8 1999 607 610
49. D. Robinson, E.M. Van Allen, Y.M. Wu, N. Schultz, R.J. Lonigro, J.M. Mosquera, B. Montgomery, M.E. Taplin, C.C. Pritchard, G. Attard, and et al. Integrative clinical genomics of advanced prostate cancer Cell 161 2015 1215 1228
50. J.S. Ross, K. Wang, C.E. Sheehan, A.B. Boguniewicz, G. Otto, S.R. Downing, J. Sun, J. He, J.A. Curran, S. Ali, and et al. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations Clin. Cancer Res. 19 2013 2668 2676
51. C.S. Ross-Innes, R. Stark, A.E. Teschendorff, K.A. Holmes, H.R. Ali, M.J. Dunning, G.D. Brown, O. Gojis, I.O. Ellis, A.R. Green, and et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer Nature 481 2012 389 393
52. B. Sahu, M. Laakso, K. Ovaska, T. Mirtti, J. Lundin, A. Rannikko, A. Sankila, J.P. Turunen, M. Lundin, J. Konsti, and et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer EMBO J. 30 2011 3962 3976
53. D. Sarrió, G. Moreno-Bueno, D. Hardisson, C. Sánchez-Estévez, M. Guo, J.G. Herman, C. Gamallo, M. Esteller, and J. Palacios Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability Int. J. Cancer 106 2003 208 215
54. A.A. Sérandour, S. Avner, F. Percevault, F. Demay, M. Bizot, C. Lucchetti-Miganeh, F. Barloy-Hubler, M. Brown, M. Lupien, R. Métivier, and et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers Genome Res. 21 2011 555 565
55. M.J. Sikora, K.L. Cooper, A. Bahreini, S. Luthra, G. Wang, U.R. Chandran, N.E. Davidson, D.J. Dabbs, A.L. Welm, and S. Oesterreich Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response Cancer Res. 74 2014 1463 1474
56. M.S. Song, L. Salmena, and P.P. Pandolfi The functions and regulation of the PTEN tumour suppressor Nat. Rev. Mol. Cell Biol. 13 2012 283 296
57. B. Strobl, D. Stoiber, V. Sexl, and M. Mueller Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity Front. Biosci. (Landmark Ed.) 16 2011 3214 3232
58. V. Theodorou, R. Stark, S. Menon, and J.S. Carroll GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility Genome Res. 23 2013 12 22
59. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121
60. C.J. Vaske, S.C. Benz, J.Z. Sanborn, D. Earl, C. Szeto, J. Zhu, D. Haussler, and J.M. Stuart Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM Bioinformatics 26 2010 i237 i245
61. J. Wang, J. Zhuang, S. Iyer, X. Lin, T.W. Whitfield, M.C. Greven, B.G. Pierce, X. Dong, A. Kundaje, Y. Cheng, and et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors Genome Res. 22 2012 1798 1812
62. M.D. Wilkerson, and D.N. Hayes ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking Bioinformatics 26 2010 1572 1573
63. M.D. Wilkerson, C.R. Cabanski, W. Sun, K.A. Hoadley, V. Walter, L.E. Mose, M.A. Troester, P.S. Hammerman, J.S. Parker, C.M. Perou, and D.N. Hayes Integrated RNA and DNA sequencing improves mutation detection in low purity tumors Nucleic Acids Res. 42 2014 e107
64. K. Wu, Q. Chang, Y. Lu, P. Qiu, B. Chen, C. Thakur, J. Sun, L. Li, A. Kowluru, and F. Chen Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells Oncotarget 4 2013 2430 2438
65. H. Zou, and T. Hastie Regularization and variable selection via the elastic net J. R. Stat. Soc., B 67 2005 301 320
66. D. Zou, H.S. Yoon, D. Perez, R.J. Weeks, P. Guilford, and B. Humar Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia J. Pathol. 218 2009 265 272